Physician profile
Timothy Beacham
NPI 1669670360
$31,284.76
in general payments reported to CMS, 2019-2025
52 companies · $2,161 in 2025
The $2,161 reported for 2025 was more than what 83% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,468 · 2020: $1,734 · 2021: $4,355 · 2022: $10K · 2023: $5,771 · 2024: $3,683 · 2025: $2,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,459 · Travel and Lodging: $1,319 · Education: $1,200 · Consulting Fee: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,459.18 |
| Travel and Lodging | $1,319.05 |
| Education | $1,200.00 |
| Consulting Fee | $637.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,686.80 | 2019-2025 | Wavewriter Alpha Prime 16, Avista Mri |
| Medtronic, INC. | $4,468.26 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Saluda Medical Americas, INC. | $4,185.93 | 2023-2025 | Evoke Scs, Evoke |
| Spinal Simplicity, LLC | $3,342.30 | 2022-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $2,044.03 | 2019-2024 | Eterna, Proclaim |
| Medtronic USA, INC. | $1,598.32 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,225.97 | 2019-2025 | Relistor |
| Nevro Corp. | $991.17 | 2019-2024 | Senza |
| Stimwave Technologies Incorporated | $534.38 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $482.02 | 2019-2024 | Xtampza, Belbuca |
| Protega Pharmaceutials INC | $349.14 | 2022-2023 | Roxybond |
| Vertos Medical, INC. | $313.66 | 2021-2024 | Mild Device Kit |
| Curonix LLC | $309.20 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $298.29 | 2020-2022 | |
| Ibsa Pharma INC. | $285.41 | 2021-2025 | Tirosint, Tirosint, Licart |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Beacham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.